Key Takeaways
- • Tilray shares surged 24% on Friday following Privateer Holdings' announcement that it will not sell its stake during the first half of 2019, easing lockup expiration concerns scheduled for the following week.
- • Privateer Holdings, the Peter Thiel-backed private equity fund, controls approximately 80% of Tilray's outstanding shares, representing the company's largest shareholder with significant influence over market supply dynamics.
- • Public float represents only 23% of Tilray's 76 million outstanding shares (approximately 17.8 million shares), with over 21% of floating shares sold short as of January 10, creating conditions for a short squeeze when positive news emerged.
- • Tilray shares have appreciated nearly 500% since the company's July Nasdaq IPO, reflecting extraordinary volatility and investor appetite for cannabis sector exposure despite regulatory uncertainty.
- • Privateer committed to distributing any future shares "in an orderly and deliberate manner" with consideration for tax efficiency and potential impacts on Tilray's public float, signaling a measured approach to capital allocation.
Summary
Tilray, a Canadian marijuana cultivator, experienced a significant single-day rally on January 11, 2019, when Privateer Holdings announced it would refrain from selling shares during the first half of 2019. The 24% gain reflected market relief following months of uncertainty surrounding the expiration of the company's IPO lockup period, which restricts insiders and venture capital investors from liquidating holdings for a specified duration after going public.
Michael Blue, a managing partner at Privateer Holdings, stated: "Privateer Holdings strongly believes in Tilray's long-term global growth strategy and pioneering role in shaping the future of the legal cannabis industry," and added that the fund has "no plans to register, sell or distribute the shares Privateer holds in Tilray during the first half of 2019." This public commitment provided clarity to equity markets regarding potential share dilution and reassured investors concerned about forced selling pressure.
The magnitude of the rally was amplified by Tilray's compressed public float and significant short interest. Of the 76 million outstanding shares, only 23% (approximately 17.8 million shares) trade publicly, while 21% of the floating supply had been sold short as of January 10. When Privateer's non-selling commitment eliminated a major downside catalyst, short sellers covering positions accelerated the upward movement—a classic short squeeze dynamic that occurs when negative catalysts fail to materialize.
Tilray's performance since its July 2018 IPO has been extraordinary, with shares appreciating nearly 500% in less than six months. This volatility reflects the emerging cannabis sector's speculative nature and retail investor enthusiasm, though it also underscores fundamental risks including regulatory uncertainty and valuation extremes. Privateer's commitment to deliberate, tax-efficient capital deployment—should future distributions occur—suggests the fund recognizes both its responsibility as a controlling shareholder and the necessity of managing market impacts from large equity blocks.
The announcement represents a material vote of confidence from one of cannabis's earliest institutional backers and addresses near-term supply concerns that had weighed on market sentiment ahead of the scheduled lockup expiration.
Michael Blue, a managing partner at Privateer Holdings, stated: "Privateer Holdings strongly believes in Tilray's long-term global growth strategy and pioneering role in shaping the future of the legal cannabis industry," and added that the fund has "no plans to register, sell or distribute the shares Privateer holds in Tilray during the first half of 2019." This public commitment provided clarity to equity markets regarding potential share dilution and reassured investors concerned about forced selling pressure.
The magnitude of the rally was amplified by Tilray's compressed public float and significant short interest. Of the 76 million outstanding shares, only 23% (approximately 17.8 million shares) trade publicly, while 21% of the floating supply had been sold short as of January 10. When Privateer's non-selling commitment eliminated a major downside catalyst, short sellers covering positions accelerated the upward movement—a classic short squeeze dynamic that occurs when negative catalysts fail to materialize.
Tilray's performance since its July 2018 IPO has been extraordinary, with shares appreciating nearly 500% in less than six months. This volatility reflects the emerging cannabis sector's speculative nature and retail investor enthusiasm, though it also underscores fundamental risks including regulatory uncertainty and valuation extremes. Privateer's commitment to deliberate, tax-efficient capital deployment—should future distributions occur—suggests the fund recognizes both its responsibility as a controlling shareholder and the necessity of managing market impacts from large equity blocks.
The announcement represents a material vote of confidence from one of cannabis's earliest institutional backers and addresses near-term supply concerns that had weighed on market sentiment ahead of the scheduled lockup expiration.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.